BioCentury
ARTICLE | Company News

Pepscan Therapeutics, J&J deal

September 27, 2010 7:00 AM UTC

Pepscan will use its Chemical LInkage of Peptides onto Scaffolds (CLIPS) technology to develop a peptide against an undisclosed target from Johnson & Johnson's Tibotec Pharmaceuticals Ltd. unit. CLIPS...